This inventor holds 1 USPTO granted patent. Top assignees: Genzyme Corporation, Harvard College, Massachusetts Institute of Technology. Active years: 2014.
Company Filing History:
1 out of 823 
1 out of 3,069 
1 out of 8,573 
Years Active: 2014
Title: Michael L Booker: Innovator in Dihydroorotate Dehydrogenase Inhibitors
Introduction
Michael L Booker is a notable inventor based in Bridgewater, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for dihydroorotate dehydrogenase (DHODH). His work has implications for treating various parasitic infections.
Latest Patents
Michael L Booker holds 1 patent related to his research. His patent focuses on inhibitors of dihydroorotate dehydrogenase, which have been identified and characterized for their high specificity and submicromolar efficacy against cultured parasite strains. These inhibitors exhibit drug-like properties and are not overtly cytotoxic, making them promising candidates for further development.
Career Highlights
Throughout his career, Michael has worked with prominent organizations such as Genzyme Corporation and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Michael has collaborated with talented individuals, including Cassandra Celatka and Cecilia M Bastos. Their combined expertise has enhanced the quality and impact of their research endeavors.
Conclusion
Michael L Booker is a distinguished inventor whose work on dihydroorotate dehydrogenase inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for potential new treatments for parasitic infections.